A0A2J8VK62 (A0A2J8VK62_PONAB) Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)
PFKFB3 isoform 13 UniProtKBInterProInteractive Modelling
520 aa; Sequence (Fasta) ;
5 identical sequences: Homo sapiens: Q16875; Pan troglodytes: H2Q1L1, A0A6D2VT16; Pan paniscus: A0A2R8ZUU5; Gorilla gorilla gorilla: A0A2I2ZVY7
It is possible new templates exist for this target since these models were created.
Available Structures
26 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| S-glutathionylated PFKFB3 | homo-2-mer | 100.0 | 2×ADP; 4×MLA; 2×ACY; 2×GSH; 2×F6P; | |||
| PFKFB3 in complex with ADP and PEP | homo-2-mer | 100.0 | 2×F6P; 2×ADP; 2×PEP; | |||
| Crystal structure of PFKFB3 in complex with ADP and Fructose-2,6-bisphosphate | homo-2-mer | 100.0 | 2×FDP; 2×F6P; 2×ADP; 2×PHS; | |||
| PFKFB3 trapped in a phospho-enzyme intermediate state | homo-2-mer | 100.0 | 2×FDP; 2×PHS; 2×ADP; 2×F6P; | |||
| Human PFKFB3 in complex with an indole inhibitor 6 | homo-2-mer | 100.0 | 2×PHS; 4×PO4; 2×F6P; 2×8V1; | |||
| Human PFKFB3 in complex with an indole inhibitor 2 | homo-2-mer | 100.0 | 2×PHS; 2×PO4; 2×F6P; 2×S6L; | |||
| human PFKFB3 in complex with a pyrrolopyrimidone compound | homo-2-mer | 100.0 | 2×PO4; 2×PHS; 2×F6P; 2×BKI; | |||
| human PFKFB3 in complex with a pyrrolopyrimidone compound | homo-2-mer | 100.0 | 2×PHS; 2×PO4; 2×F6P; 2×BKS; | |||
| human PFKFB3 in complex with a pyrrolopyrimidone compound | homo-2-mer | 100.0 | 2×PHS; 2×PO4; 2×F6P; 2×BKE; | |||
| PFKFB3 in complex with PPi | homo-2-mer | 100.0 | 6×POP; 4×SRT; 4×EDO; | |||
| human PFKFB3 in complex with a pyrrolopyrimidone compound | homo-2-mer | 100.0 | 4×PO4; 2×PHS; 2×F6P; 2×BKV; | |||
| Human PFKFB3 in complex with an indole inhibitor 5 | homo-2-mer | 100.0 | 2×PHS; 2×F6P; 2×PO4; 2×MJP; | |||
| Human PFKFB3 in complex with an indole inhibitor 4 | homo-2-mer | 100.0 | 2×PHS; 2×PO4; 2×F6P; 2×87T; | |||
| Human PFKFB3 in complex with an indole inhibitor 3 | homo-2-mer | 100.0 | 2×PHS; 2×PO4; 2×F6P; 2×FD9; | |||
| Human PFKFB3 in complex with an indole inhibitor 1 | homo-2-mer | 100.0 | 6×PO4; 2×8R2; 2×FDP; | |||
| A pseudo substrate complex of 6-phosphofructo-2-kinase of PFKFB | homo-2-mer | 100.0 | 4×F6P; 2×MG; 2×ACP; | |||
| HUMAN PFKFB3 IN COMPLEX WITH KAN0438241 | homo-2-mer | 100.0 | 2×DMS; 2×F6P; 2×BWW; 2×ADP; | |||
| PFKFB3 in complex with Aluminum Tetrafluoride | homo-2-mer | 100.0 | 2×ALF; 2×ADP; 2×PEP; 2×CL; | |||
| Crystal structure of the human inducible form 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase | monomer | 100.0 | 1×F6P; 1×EDT; 1×ADP; | |||
| Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 2 | monomer | 100.0 | 1×GV5; 1×POP; 1×F6P; 1×FLC; 1×DMS; | |||
| Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 5 | monomer | 100 | 1×H9Z; 1×POP; 1×FLC; 1×F6P; 1×DMS; | |||
| Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 3 | monomer | 100.0 | 1×GV8; 1×F6P; 1×PO4; 1×FLC; | |||
| Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 1 | monomer | 100.0 | 1×GV2; 1×POP; 1×FLC; 1×F6P; | |||
| Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 7 | monomer | 100 | 1×PO4; 1×FLC; 1×HAW; 1×F6P; | |||
| Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 6 | monomer | 100 | 1×HAT; 1×POP; 1×FLC; 1×F6P; 1×BME; 1×PO4; | |||
| Human PFKFB3 in complex with a N-Aryl 6-Aminoquinoxaline inhibitor 4 | monomer | 100 | 1×HAK; 1×POP; 1×FLC; 1×F6P; 1×DMS; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5ak0.1.B | homo-2-mer | 0.86 | 2×PHS; 2×F6P; 2×8V1; | 100.00 | ||